Skip to main content
. 2023 Apr 25;3(3):335–345. doi: 10.1016/j.jacasi.2023.02.004

Table 1.

ICD Therapy for Primary and Secondary Prevention in Western Countries and Asia

Sabbag et al.33 van Welsenes et al30 Aonuma et al.37 Kabutoya et al.51 Kotake et al.31 Yokoshiki et al.36 Cho et al.4 Park et al.32
n 2,349 2,134 171 392 985 17,564 305 146
Year 2015 2011 2022 2021 2021 2020 2020 2017
Country Israel the Netherlands Japan Japan Japan Japan Korea Korea
Primary/secondary, % 75/25 61/39 100/0 42/58 54/46 26/74 55/45 25/75
ICM/NICM, % 84/16 70/30 42/58 100/0 42/58 36/64 43/57 50/50
Appropriate ICD therapy/ICD shock 3.9/1.1 (1 y) 37 (5 y)/20 (5 y) 10 (24 mo)/NA 20 (20 mo)/9 (20 mo) 22 (36 mo)/NA NA 18/12 (31 mo) NA/39 (42 mo)

ICD = implantable cardioverter-defibrillator; ICM = ischemic cardiomyopathy; NA = not available; NICM = nonischemic cardiomyopathy.